Lupus & antiphospholipid syndrome

Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

Arthritis RheumatolPublished Longitudinal cohort study

Authors' conclusion

Treatment with HCQ and incident vascular events in aPL-positive patients predicted significant anti-D1 and anti-β2 GPI titer fluctuations over time. Both anti-D1 and anti-β2 GPI titers decreased around the time of thrombosis, with potential clinical relevance.

Study context

Population
Patients persistently positive for aPL in the APS ACTION Registry with blood samples from at least 4 time points
Participants
230 participants
Outcome
Longitudinal anti-β2 GPI and anti-D1 IgG titers; predictors of titer variation; whether titer fluctuations predict thrombosis
Follow-up
Years 1-4
Methodological detailsinternational registry (APS ACTION Registry), samples from at least 4 time points (baseline [year 1] and years 2-4), chemiluminescence (BIO-FLASH)
  • International registry (APS ACTION Registry)
  • Samples from at least 4 time points (baseline [year 1] and years 2-4)
  • Chemiluminescence (BIO-FLASH)

Main finding

As reported in the abstract

Anti-D1 titers decreased significantly over time
P < 0.0001
Anti-β2 GPI titers decreased significantly over time
P = 0.010
Hydroxychloroquine (HCQ) (not immunosuppressive agents) associated with decrease in anti-D1 titers (adjusted for age, sex, number of positive aPL tests)
1.3-fold
HCQ (not immunosuppressive agents) associated with decrease in anti-β2 GPI titers (adjusted for age, sex, number of positive aPL tests)
1.4-fold
Incident vascular events associated with increase in anti-D1 titers
1.9-fold
Incident vascular events associated with increase in anti-β2 GPI titers
2.1-fold

Observational data: associations, not effects.

Further findings

Incident thrombosis by titer decrease

OR (95% CI)
1.6-fold decrease in anti-D1 titers6.0 (0.62–59.3)
2-fold decrease in anti-β2 GPI titers9.4 (1.1–80.2)

Original publication

Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies. Arthritis Rheumatol. Published 2 April 2023. doi:10.1002/art.42459

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.